HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.

Abstract
VV-Hemorphin-5 is an endogenous opioid peptide of the Hemorphin family with affinity at opioid receptors. A series of C-amide analogues have been synthesized, based on the structure of VV-Hemorphin-5, modified at position 1 and 7 by the un/natural amino acids (Aa8-Val-Val-Tyr-Pro-Trp-Thr-Gln-NH2 and Val-Val-Tyr-Pro-Trp-Thr-Aa1-NH2 ) using SPPS, Fmoc-chemistry. The peptide derivatives were evaluated for their anticonvulsant activity in three acute seizure tests in male ICR mice, the maximal electroshock (MES), the 6 Hz psychomotor seizure test, and the timed intravenous pentylenetetrazole (ivPTZ) infusion test. Their neurotoxicity was assessed in the rotarod test. Among the tested peptide analogues, V4 showed anticonvulsant activity in the three seizure tests that was comparable to the VV-Hemorphin-5 (V1) used as a positive control. While V5, V6, and V7 peptide derivatives exhibited anticonvulsant activity in the MES and 6 Hz test, they were inactive (V7) or showed pro-convulsant effect (V5 and V6) in the i.v. PTZ test. At a dose of 10 μg/mouse the peptide V2 was effective against clonic seizures induced by PTZ. Motor coordination was not affected by newly developed analogues of VV-Hemorphin-5. Docking study results suggest that kappa opioid receptor binding could be the mechanism of action of peptide derivatives with anticonvulsant activity. The results suggest that incorporation of nonproteinogenic and/or natural amino acids at position 1 and 7 of the VV-Hemorphin-5 scaffold deserve further evaluation in models of epilepsy and derivatization.
AuthorsPetar Todorov, Miroslav Rangelov, Petia Peneva, Nadezhda Todorova, Jana Tchekalarova
JournalDrug development research (Drug Dev Res) Vol. 80 Issue 4 Pg. 425-437 (06 2019) ISSN: 1098-2299 [Electronic] United States
PMID30681179 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 Wiley Periodicals, Inc.
Chemical References
  • Anticonvulsants
  • Hemoglobins
  • Opioid Peptides
  • Peptide Fragments
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • VV-hemorphin-5
  • Pentylenetetrazole
Topics
  • Amino Acid Sequence
  • Animals
  • Anticonvulsants (chemical synthesis, chemistry, pharmacology)
  • Electroshock
  • Hemoglobins (chemical synthesis, chemistry, pharmacology)
  • Male
  • Mice, Inbred ICR
  • Molecular Docking Simulation
  • Molecular Structure
  • Opioid Peptides (chemical synthesis, chemistry, pharmacology)
  • Pentylenetetrazole
  • Peptide Fragments (chemical synthesis, chemistry, pharmacology)
  • Protein Binding
  • Psychomotor Performance (drug effects)
  • Receptors, Opioid, delta (metabolism)
  • Receptors, Opioid, kappa (metabolism)
  • Seizures (drug therapy)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: